A new course examines the issue of insomnia
Guild Learning and Development is partnering with MSD in an online course titled Belsomra® (suvorexant): A different way to manage insomnia.
This course explores the role of Belsomra® (suvorexant) in treating insomnia, including the clinical findings on sleep onset, sleep maintenance and total sleep time.
This course will also assist pharmacists to identify the safety considerations for patients prescribed Belsomra® (suvorexant) as well as the key counselling points that should be provided.
This activity has been accredited for 0.75 hours of Group 1 CPD (or 0.75 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 0.75 hours of Group 2 CPD (or 1.5 CPD credits) upon successful completion of relevant assessment activities.
Surveys have shown that 13-33% of the adult population in Australia have regular difficulty either getting to sleep or staying asleep.1
Insufficient sleep and sleep disorders can affect a person’s health and wellbeing and have broader social consequences.
The Guild Pharmacy Academy has thanked MSD Australia Pty Ltd for their financial support and input of expertise in the development of this course.
1 Cunnington, D., Junge, M. F., & Fernando, A. T. (2013). Insomnia: prevalence, consequences and effective treatment. Med J Aust, 199(8), S36-40